Shuttle Pharmaceuticals Has Received A Notice Of Allowance For Patent Application Titled ‘SELECTIVE HISTONE DEACETYLASE INHIBITORS FOR THE TREATMENT OF HUMAN DISEASE (INCLUDING CANCER AND IMMUNOLOGICAL, INFLAMMATORY, & NEUROLOGICAL DISEASES)’
https://patentcenter.uspto.gov/#!/applications/17315567/ifw/docs
